HHS Calls for Authority to Negotiate Medicare Drug Prices (2)

Sept. 9, 2021, 1:30 PM UTCUpdated: Sept. 9, 2021, 1:43 PM UTC

The Biden administration is calling for Congress to pass a set of proposals already backed by Democrats to lower prescription drug prices, including one to let the government negotiate prices with drugmakers.

The proposals unveiled Thursday are part of a long-awaited report from the HHS to the White House that offers a wide-ranging series of recommendations on curbing rising drug costs. Lawmakers have pushed for much of these proposals for years, and former President Donald Trump took action on some.

The Health and Human Services Department attributed the high cost of prescription drug prices in the U.S. to “lack of ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.